BEBRF logo Benign Essential Blepharospasm Research Foundation (BEBRF)

Home   Blepharospasm   Related disorders   Treatments   Patient support   The BEBRF   FAQ   Blepharospasm
  Site Search

 What's new 
 Contact us 
 Other ways to help fund BEBRF 
 BEBRF on-line store 
 On-line resources 
 Medical Information 
 Dystonia advocacy 
 Blepharospasm Bulletin Board 
 Subscribe to newsletter 

Botulinum Toxin Treatment Assistance Programs

Some blepharospasm patients are finding it difficult to pay for their injection treatments. Below are two programs that may help those who qualify.

  1. The BOTOX PATIENT ASSISTANCE® PROGRAM is dedicated to helping financially eligible patients. There are certain financial and other requirements that must be met to qualify for the program. Patient must:
    • Be uninsured or underinsured
    • Have income less than or equal to 500% of the Federal Poverty Level
    • Be a resident of the United States or Puerto Rico

    More information is available at: or by calling the Botox hotline: 1-800-44-BOTOX (1-800-442-6869). A Reimbursement Counselor can help answer any questions and send you an application.

  2. The XEOMIN® PATIENT SAVINGS PROGRAM is designed to support eligible patients with their actual out-of-pocket XEOMIN medication costs and related administration fees, up to a maximum amount of $3,500 per rolling 12-month period. The initial 12-month period begins with a patient's acceptance into the Program (no earlier than July 1, 2016).
    To be eligible, patient must:
    • Be a clinically appropriate patient for therapeutic treatment with XEOMIN, as determined by your doctor
    • Be prescribed XEOMIN®
    • Be at least 18 years of age
    • Have commercial insurance that covers XEOMIN medication cost
    • Not be enrolled in a state or federally funded prescription insurance program
    • Further restrictions apply to eligibility and reimbursable expenses
    More information is available at or by calling 1-888-493-6646 between 8 am and 8 pm ET.

Note that although Dysport and MYOBLOC may be prescribed for blepharospasm, this not an on-label use for these products. As such, blepharospasm patients are not eligible for the manufacturers' financial assistance programs.

Home > Treatments > Botulinum Toxin > Top of this page

Disclaimer Site map Webmaster Dedication Updated: October 2018